Hemospray (TC-325) Versus Standard Endoscopic Therapy For Non-Variceal Gastrointestinal Bleeding (NVGIB) - A Systematic Review & Meta-Analysis Of Randomized Controlled Trials

Authors

Saurabh Chandan, CHI Creighton School of Medicine, Omaha, NE
Smit Deliwala
Babu Mohan, University of Utah School of Medicine, Salt Lake City, Utah
Shahab Khan
Nitin Reddy
Daryl Ramai, University of Utah School of Medicine, Salt Lake City, UT
Jay Bapaye, Rochester Regional HealthFollow
Lena L. Kassab, Mayo Clinic, Rochester, Minnesota
Antonio Facciorusso, Gastroenterology Unit, University of Foggia, Foggia, Italy.
Saurabh Chawla
Douglas Adler

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Gastrointestinal Endoscopy

Conference Name

Digestive Disease Week

Conference Date

2023-05-06 - 2023-05-09

First Page

AB140

DOI

10.1016/j.gie.2023.04.241

Volume

97

Issue

6, Supplement

Publication Date

6-1-2023

Recommended Citation

Chandan, S., Deliwala, S., Mohan, B., Khan, S., Reddy, N., Ramai, D., Bapaye, J., Kassab, L. L., Facciorusso, A., Chawla, S., & Adler, D. (2023). Hemospray (TC-325) Versus Standard Endoscopic Therapy For Non-Variceal Gastrointestinal Bleeding (NVGIB) - A Systematic Review & Meta-Analysis Of Randomized Controlled Trials. Gastrointestinal Endoscopy, 97 (6, Supplement), AB140. https://doi.org/10.1016/j.gie.2023.04.241